127252-80-6: Clarithromycin EP Impurity O

Clarithromycin EP Impurity O (CAS No: 127252-80-6) or 6-O-Methylerythromycin A (Z)-9-(O-methyloxime) is a chemical modification of erythromycin. Erythromycin is a macrolide that functions by blocking the translocation reaction at the time of protein synthesis. Erythromycin, except under alkaline conditions, is inactive against Enterobacteriaceae and Pseudomonas aeruginosa.

Additional information on CAS 127252-80-6

Catalogue No.

VL740015

CAS No.

127252-80-6

Molecular Formula

C39H72N2O13

Molecular Weight

776.99

Parent drug

Clarithromycin

IUPAC Name

6-O-Methylerythromycin A (Z)-9-(O-methyloxime)

Synonyms

Clarithromycin (9Z)-O-Methyloxime

References

WATANABE, YOSHIAKI, et al. “Chemical Modification of Erythromycins. IX. Selective Methylation at the C-6 Hydroxyl Group of Erythromycin a Oxime Derivatives and Preparation of Clarithromycin.” The Journal of Antibiotics, vol. 46, no. 4, 1993, pp. 647–60, https://doi.org/10.7164/antibiotics.46.647. WASHINGTON, JOHN A., and WALTER R. WILSON. “Erythromycin: A Microbial and Clinical Perspective after 30 Years of Clinical Use (First of Two Parts).” Mayo Clinic Proceedings, vol. 60, no. 3, Mar. 1985, pp. 189–203, https://doi.org/10.1016/s0025-6196(12)60219-5. ‌

Status

In-stock

Request a quote

127252-80-6: Clarithromycin EP Impurity O

127252-80-6: Clarithromycin EP Impurity O
Catalogue No.

VL740015

CAS No.

127252-80-6

Molecular Formula

C39H72N2O13

Molecular Weight

776.99

Parent drug

Clarithromycin

IUPAC Name

6-O-Methylerythromycin A (Z)-9-(O-methyloxime)

Synonyms

Clarithromycin (9Z)-O-Methyloxime

References

WATANABE, YOSHIAKI, et al. “Chemical Modification of Erythromycins. IX. Selective Methylation at the C-6 Hydroxyl Group of Erythromycin a Oxime Derivatives and Preparation of Clarithromycin.” The Journal of Antibiotics, vol. 46, no. 4, 1993, pp. 647–60, https://doi.org/10.7164/antibiotics.46.647. WASHINGTON, JOHN A., and WALTER R. WILSON. “Erythromycin: A Microbial and Clinical Perspective after 30 Years of Clinical Use (First of Two Parts).” Mayo Clinic Proceedings, vol. 60, no. 3, Mar. 1985, pp. 189–203, https://doi.org/10.1016/s0025-6196(12)60219-5. ‌

Status

In-stock

ListName

Clarithromycin EP Impurity O

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url